A systematic literature review and meta-analysis on the efficacy and safety of PD-(L)1 inhibitors for the first- and second-line treatment of locally advanced or metastatic non-small cell lung cancer in Asian and non-Asian patients.
- DOI
- 10.21037/tlcr-2025-746
- Published
- 2025 Dec 31
- Container
- Translational lung cancer research
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.21037/tlcr-2025-746,
title = {A systematic literature review and meta-analysis on the efficacy and safety of PD-(L)1 inhibitors for the first- and second-line treatment of locally advanced or metastatic non-small cell lung cancer in Asian and non-Asian patients.},
author = {Girard N and Tan D and Cortinovis D and Lopes G and Voon PJ and Taylor MA and Ghali N and Zhan L and Xu S and Naicker K and Peters S},
year = {2025},
journal = {Translational lung cancer research},
doi = {10.21037/tlcr-2025-746},
url = {https://doi.org/10.21037/tlcr-2025-746}
}RIS
TY - JOUR TI - A systematic literature review and meta-analysis on the efficacy and safety of PD-(L)1 inhibitors for the first- and second-line treatment of locally advanced or metastatic non-small cell lung cancer in Asian and non-Asian patients. AU - Girard N AU - Tan D AU - Cortinovis D AU - Lopes G AU - Voon PJ AU - Taylor MA AU - Ghali N AU - Zhan L AU - Xu S AU - Naicker K AU - Peters S PY - 2025 JO - Translational lung cancer research DO - 10.21037/tlcr-2025-746 UR - https://doi.org/10.21037/tlcr-2025-746 ER -
APA
N, G., D, T., D, C., G, L., PJ, V., MA, T., N, G., L, Z., S, X., K, N., & S, P. (2025). A systematic literature review and meta-analysis on the efficacy and safety of PD-(L)1 inhibitors for the first- and second-line treatment of locally advanced or metastatic non-small cell lung cancer in Asian and non-Asian patients.. Translational lung cancer research. https://doi.org/10.21037/tlcr-2025-746
Source records
- pubmed · retrieved 2026-09-27T11:02:32.859Z